Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Improvement of glucose homeostasis in obese diabetic db/db mice given Plasmodium yoelii glycosylphosphatidylinositols.

Elased KM, Gumaa KA, de Souza JB, Playfair JH, Rademacher TW.

Metabolism. 2004 Aug;53(8):1048-53.

PMID:
15281017
2.

Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs).

Elased KM, Gumaa KA, de Souza JB, Rahmoune H, Playfair JH, Rademacher TW.

Mol Genet Metab. 2001 Jul;73(3):248-58.

PMID:
11461192
3.

Reversal of type 2 diabetes in mice by products of malaria parasites: I. Effect of inactivated parasites.

Elased KM, de Souza JB, Playfair JH.

Metabolism. 2000 Jul;49(7):937-41.

PMID:
10910007
4.

DNA vaccination favours memory rather than effector B cell responses.

Laylor R, Porakishvili N, De Souza JB, Playfair JH, Delves PJ, Lund T.

Clin Exp Immunol. 1999 Jul;117(1):106-12.

5.

Premature removal of uninfected erythrocytes during malarial infection of normal and immunodeficient mice.

Salmon MG, De Souza JB, Butcher GA, Playfair JH.

Clin Exp Immunol. 1997 Jun;108(3):471-6.

6.

Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria.

De Souza JB, Williamson KH, Otani T, Playfair JH.

Infect Immun. 1997 May;65(5):1593-8.

7.

Malaria, blood glucose, and the role of tumour necrosis factor (TNF) in mice.

Elased KM, Taverne J, Playfair JH.

Clin Exp Immunol. 1996 Sep;105(3):443-9.

9.

Structural similarities among malaria toxins insulin second messengers, and bacterial endotoxin.

Caro HN, Sheikh NA, Taverne J, Playfair JH, Rademacher TW.

Infect Immun. 1996 Aug;64(8):3438-41.

10.

Reversal of hypoglycaemia in murine malaria by drugs that inhibit insulin secretion.

Elased KM, Playfair JH.

Parasitology. 1996 Jun;112 ( Pt 6):515-21.

PMID:
8684825
11.

Malaria: a tumour necrosis factor inhibitor from parasitized erythrocytes.

Sheikh NA, Caro HN, Taverne J, Playfair JH, Rademacher TW.

Immunology. 1996 Mar;87(3):461-6.

12.

A novel adjuvant for use with a blood-stage malaria vaccine.

de Souza JB, Playfair JH.

Vaccine. 1995 Oct;13(14):1316-9.

PMID:
8585286
13.

Malaria: toxins, cytokines and disease.

Jakobsen PH, Bate CA, Taverne J, Playfair JH.

Parasite Immunol. 1995 May;17(5):223-31. Review.

PMID:
7675508
14.

Blood-stage malaria infection in diabetic mice.

Elased K, De Souza JB, Playfair JH.

Clin Exp Immunol. 1995 Mar;99(3):440-4.

15.

The pathology of malaria: a possible target for immunisation?

Playfair JH.

Immunol Lett. 1994 Dec;43(1-2):83-6. Review. No abstract available.

PMID:
7737694
16.

Hypoglycemia and hyperinsulinemia in rodent models of severe malaria infection.

Elased K, Playfair JH.

Infect Immun. 1994 Nov;62(11):5157-60.

17.

Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor.

Taverne J, Sheikh N, de Souza JB, Playfair JH, Probert L, Kollias G.

Immunology. 1994 Jul;82(3):397-403.

18.

Immunizing against toxic malarial antigens: reply.

Bate C, Kwiatkowski DP, Taverne J, Playfair JH.

Parasitol Today. 1994 Jan;10(1):24. No abstract available.

PMID:
15275560
19.

Heidikines.

Playfair JH.

Immunol Today. 1993 Sep;14(9):469. No abstract available.

PMID:
8216726
20.

Cytokine-antigen vaccines.

Heath AW, Playfair JH.

Nature. 1993 Aug 5;364(6437):493. No abstract available.

PMID:
8336789
21.
22.

Tumour necrosis factor and interleukin-6 production induced by components associated with merozoite proteins of Plasmodium falciparum.

Jakobsen PH, Moon R, Ridley RG, Bate CA, Taverne J, Hansen MB, Takacs B, Playfair JH, McBride JS.

Parasite Immunol. 1993 Apr;15(4):229-37.

PMID:
8506119
23.

Malarial toxic antigens synergistically enhance insulin signalling.

Taylor K, Carr R, Playfair JH, Saggerson ED.

FEBS Lett. 1992 Oct 26;311(3):231-4.

24.

Phospholipid-containing toxic malaria antigens induce hypoglycaemia.

Taylor K, Bate CA, Carr RE, Butcher GA, Taverne J, Playfair JH.

Clin Exp Immunol. 1992 Oct;90(1):1-5.

25.

The potential of cytokines as adjuvants.

Heath AW, Playfair JH.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1401-3. Review. No abstract available.

PMID:
1466967
26.

Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens.

Bate CA, Taverne J, Bootsma HJ, Mason RC, Skalko N, Gregoriadis G, Playfair JH.

Immunology. 1992 May;76(1):35-41.

27.
28.

Serological relationship of tumor necrosis factor-inducing exoantigens of Plasmodium falciparum and Plasmodium vivax.

Bate CA, Taverne J, Karunaweera ND, Mendis KN, Kwiatkowski D, Playfair JH.

Infect Immun. 1992 Mar;60(3):1241-3.

29.

Cytokines as immunological adjuvants.

Heath AW, Playfair JH.

Vaccine. 1992;10(7):427-34. Review. Erratum in: Vaccine 1992;10(11):808.

PMID:
1609545
30.

Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid.

Bate CA, Taverne J, Román E, Moreno C, Playfair JH.

Immunology. 1992 Jan;75(1):129-35.

31.

Toxins, cytokines, immunity and pathology.

Playfair JH.

Immunol Lett. 1991 Oct;30(2):145-8. Review. No abstract available.

PMID:
1757100
32.
33.

Evaluation of TNF as antiviral, antibacterial and antiparasitic agent.

Rook GA, Taverne J, Playfair JH.

Biotherapy. 1991;3(2):167-75. Review. No abstract available.

PMID:
2054257
34.

Don't kill the parasite: control the disease.

Playfair JH, Taverne J, Bate CA.

Acta Leiden. 1991;60(1):157-65.

PMID:
1820705
35.

Conjugation of interferon-gamma to antigen enhances its adjuvanticity.

Heath AW, Playfair JH.

Immunology. 1990 Nov;71(3):454-6.

36.

Tumor necrosis factor and malaria. Beneficial and harmful aspects.

Playfair JH.

Diagn Microbiol Infect Dis. 1990 Sep-Oct;13(5):435-8. Review. No abstract available.

PMID:
2282779
37.

Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages.

Taverne J, Bate CA, Kwiatkowski D, Jakobsen PH, Playfair JH.

Infect Immun. 1990 Sep;58(9):2923-8.

38.

Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody.

Taverne J, Bate CA, Playfair JH.

Immunol Lett. 1990 Aug;25(1-3):207-12.

PMID:
2283151
39.

Non-specific killing mechanisms effective against blood stage malaria parasites.

Playfair JH.

Immunol Lett. 1990 Aug;25(1-3):173. No abstract available.

PMID:
2283146
40.

Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF.

Bate CA, Taverne J, Davé A, Playfair JH.

Immunology. 1990 Jul;70(3):315-20.

41.

Modern vaccines. Parasitic diseases.

Playfair JH, Blackwell JM, Miller HR.

Lancet. 1990 May 26;335(8700):1263-6. Review. No abstract available.

PMID:
1971332
42.
43.

The malaria vaccine: anti-parasite or anti-disease?

Playfair JH, Taverne J, Bate CA, de Souza JB.

Immunol Today. 1990 Jan;11(1):25-7. Review.

PMID:
2405875
44.

Inhibition of intraerythrocytic development of Plasmodium falciparum by proteinase inhibitors.

Rockett KA, Playfair JH, Ashall F, Targett GA, Angliker H, Shaw E.

FEBS Lett. 1990 Jan 1;259(2):257-9.

45.

Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum.

Taverne J, Bate CA, Sarkar DA, Meager A, Rook GA, Playfair JH.

Parasite Immunol. 1990 Jan;12(1):33-43.

PMID:
2179828
46.

The role of reactive oxygen intermediates in vitro and in vivo: some comments.

Rockett KA, Playfair JH.

Blood Cells. 1990;16(2-3):602-4. No abstract available.

PMID:
2096988
47.

Killing of Plasmodium falciparum by human monocyte-derived macrophages.

Jones KR, Cottrell BJ, Targett GA, Playfair JH.

Parasite Immunol. 1989 Nov;11(6):585-92.

PMID:
2515516
48.

Interferon-gamma as an adjuvant in immunocompromised mice.

Heath AW, Devey ME, Brown IN, Richards CE, Playfair JH.

Immunology. 1989 Aug;67(4):520-4.

49.

Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages.

Moreno C, Taverne J, Mehlert A, Bate CA, Brealey RJ, Meager A, Rook GA, Playfair JH.

Clin Exp Immunol. 1989 May;76(2):240-5.

50.

Supplemental Content

Loading ...
Support Center